chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Numbing and dead arm feeling; arm discomfort; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the arm left on an unknown date in Mar2021 at 18:00 (at the age of 27-year-old) and the patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the arm left on 26Mar2021 at 18:00 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021 the patient experienced some numbing and discomfort around just the upper left arm area after the first shot, but not nearly as significant as the second shot, and it never came back like it was now (at the time of this report). After receiving the second dose, on 26Mar2021 at 18:00, the patient experienced numbing and dead arm feeling in upper left arm, extending into the armpit area and side of upper left chest area immediately, it went away after 1-2 hours and dead arm/discomfort returned 8-11 days later. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. On 22Mar2021, the patient underwent COVID-19 PCR test (nasal swab) and the result was negative. No therapeutic measures were taken as a result of the events. The clinical outcome of the event numbing and dead arm feeling and arm discomfort was not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
Severe Pain in left shoulder at vaccine site: Upper left arm swollen greatly (balloon size), Heart palpitations and some shortness of breath.
This spontaneous report as received from a Registered Nurse refers to unspecified number of patients of unknown age and gender. On unknown dates, the patients were vaccinated with improperly stored LIQUID PEDVAXHIB lot # K016965, expiry date: 20-JUL-2017, and lot # reported as: K025002 and expiry date: 20-JUL-2017 (dosage and route not provided). No adverse effects were reported. This is one of two reports received from the same reporter. Additional information has been requested.
nausea; dizziness; I just don't feel right; experienced muscle weakness; This non-serious case was reported by a consumer via call center representative and described the occurrence of nausea in a 74-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13-OCT-2023, the patient received the 1st dose of Shingrix (left arm). In OCT-2023, an unknown time after receiving Shingrix, the patient experienced nausea (Verbatim: nausea) and dizziness (Verbatim: dizziness). On an unknown date, the patient experienced feeling abnormal (Verbatim: I just don't feel right) and muscle weakness (Verbatim: experienced muscle weakness). In OCT-2023, the outcome of the nausea and dizziness were resolved. The outcome of the feeling abnormal and muscle weakness were not resolved.   It was unknown if the reporter considered the nausea, dizziness, feeling abnormal and muscle weakness to be related to Shingrix.     It was unknown if the company considered the nausea, dizziness, feeling abnormal and muscle weakness to be related to Shingrix.   Additional Information: GSK Receipt Date: 17-OCT-2023 The reporter stated that he received Shingrix dose 1 and experienced muscle weakness, nausea and dizziness. The patient just didn't feel right. Referred to healthcare professional. MI phone number provided. The reporter did not consent to follow-up.
Bell's Palsy; something felt weird; asthma; facial numbness and tingling; facial numbness and tingling; This is a spontaneous report from a contactable consumer (patient). A 51-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection),  dose 1 via an unspecified route of administration administered in arm left on 05Apr2021 (Batch/Lot Number: ER8727) at age of 51 years old as single dose for covid-19 immunisation. There was no medical history.  There was no history of all previous immunization with the Pfizer vaccine considered as suspect. No additional vaccines administered on same date of the Pfizer suspect. No prior vaccinations within 4 weeks. No events following prior vaccinations. There were no concomitant medications.  The patient had her 1st dose of Pfizer Covid-19 vaccine on Monday morning (05Apr2021).  The patient experienced facial numbness and tingling on 05Apr2021. After the injection she sat and waited for 15 minutes. When she got in the car, she felt her face tingling.  It had been a couple days of having the sensation in her face.  She called her physician and it was labeled as Bell's Palsy.  Her physician suggested she phone and report her experience. She had her appointment at 11:30. She was back in her car around 13:00. She noticed as she was driving, that something felt weird.  She didn't know if it was numbness or tingling.  She added it was not painful and she was not distorted.  She thought it's numb. Her physician advised she take Motrin.  Her physician shared an article about a trial that some people may experience this after, it included 4-5 people. Her symptoms shifted.  First in her cheeks, then over the course of yesterday and today, she feels it's on the side of her face.  The forehead had gone away, but it's on the right side of her face.  She added the symptoms were improving and clarified they were persisting. She had asthma and wanted to minimize the severity of Covid if she would ever get it. She had loved ones around and added that you never know.  She wanted to protect herself. She wanted to get out and see her family and friends. Some of them have already been fully vaccinated. She was concerned when it started. It wasn't affecting her breathing, but she called her physician and asked if she needed to come in.  Her physician suggested to just monitor it. The events did not require visit to emergency room or physician office. The outcome of events facial numbness and tingling was not recovered. The outcome of other events was unknown.
Narrative: COVID infection following COVID vaccine series 02/19 Pfizer, dose #1 03/12, Pfizer, dose #2 08/05 pt cc: cough, fatigue, headache, myalgias, rhinorrhea sore throat, exposure: SON 08/09 COVID swab, result: detected 08/10-08/16 pt symptoms continue 08/17 clinically resolved
The patient's height, and weight were not reported. The patient's pre-existing medical conditions included unknown. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and batch number: 1805018 expiry: UNKNOWN) dose was not reported, administered on 13-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 13-MAR-2021, the subject experienced chills, fever and severe headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills on 14-MAR-2021, and fever, and had not recovered from severe headache. This report was non-serious.
tuberculin syringe and needle used to administer Moderna booster; This spontaneous case was reported by a nurse and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (tuberculin syringe and needle used to administer Moderna booster) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (tuberculin syringe and needle used to administer Moderna booster). At the time of the report, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (tuberculin syringe and needle used to administer Moderna booster) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication use was unknown Treatment information was unknown
Patient Received Johnson Johnson vaccine in right deltoid on 08/02/2021 and 2 days later developed right shoulder sharp pain with tingling sensation and right posterior hip pain with tingling sensation
This spontaneous report as received from a medical technologist (MT) via a company representative refers to approximately 78 year old female patient. On 09-NOV-2013, at an unspecified location the patient was administered with a dose of ZOSTAVAX dose 1. The dose, route, lot and expiration date were unspecified. Concomitant therapies included amitriptyline hydrochloride, aspirin (manufacturer unknown), atenolol, BENECOL, calcium (unspecified), DIOVAN, vitamins (unspecified), OMEGA-3, PREMARIN, PRILOSEC, probiotics (unspecified), roseada and valacyclovir hydrochloride. It was reported that these medications were listed as daily and may be recently ordered medication. The medical technologist stated that the patient reported to office 6 weeks after injection, around "Christmas time" (unknown date in December 2013) that she developed shingles. It was unspecified if the patient sought medical attention. The outcome of shingles was unknown. MT informed representative that the physician was interested in identifying viral strain from the patient. Additional information has been requested.
Papulovesicular pruritic rash that first developed on the legs and subsequently on the arms and face over 2 days after vaccines. High normal temps to 101.1 were noted. Fussiness and decreased eating/drinking though behavioral remained normal aside from mild fussiness.
Around 6 pm I got a severe headache, very bad body aches, trouble breathing, and a very fast heart rate. I felt faint and had cold sweats so I went to ER after work. The ER doctor gave me fluids, a vial of tylenol through IV, and just observed me to make sure my heart rate and blood pressure came down. They said it sounded like a normal reaction. Fever of 101. I am getting a MRI of my brain on Tuesday 3/9/21 for continued severe headaches.
Pain at injection site, head ache, fatigue, dizziness, tremors with chills, swollen arm pit/lymph node
Within a half an hour after injection, Patient complained that the left side of his tongue was numb and tingly and he felt off. It last an hour.   July 12, 2004 Patient had a polio, lot # O340N within several hours of injection his whole leg blew up and he was inconsolable for over an hour, with high pitch screams.
Nausea; chills; fever; tiredness; sore throat; body aches; This is a spontaneous report from a non-contactable healthcare professional. A 25-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. Medical history was none. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient had no allergies to medications, food, or other products. Concomitant medications were not reported. On an unspecified date, the patient experienced nausea, chills, fever, tiredness, sore throat, and body aches. No treatment was received for the adverse events. Clinical outcome of the events was recovering.  No follow up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Erythema of left upper arm around injection site, tenderness and itching around injection site.
Severe hives over entire body 2 hours after injection, especially bad on face and neck.  Felt extremely hot from the inside out. Seen at Urgent Care, given shot of Benedryl and a dose of Prednisone Symptoms continued into the next day and evening, took Benedryl every 4 hours Symptoms improved by 03/26, though not completely gone.
No additional adverse events; Medical Assistant reports the administration of improperly stored ROTATEQ; This spontaneous report has been received from other health professional (medical assistant) referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, historical drugs, concurrent conditions, concomitant therapies and previous drug reactions or allergies was not provided.   On 27-DEC-2021, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot # 1741817 has been verified to be a valid lot number, expiration date was reported and established as 30-JUL-2022; vaccination scheme, and anatomical site of vaccination were not reported), orally, 2 milliliters for prophylaxis. The administration of improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (product storage error) was reported.  The vaccine was exposed to a temperature of 50.5 F, for a time frame of 57 minutes. There were no previous temperature excursions. No additional adverse event were reported.
Client stated she had participated in a trial for Regeneron, last therapy was 12/31/2020 (received 3 of 6 injections). Stated she had a negative COVID-19 antibody test the week before holiday. She assumed that she was a placebo recipient. She contacted the study and asked about getting the COVID-19 vaccine. She stated that she was not advised either way to get vaccine or not. She will no longer participate in the Regeneron study, but will do follow up appointment. Discussed CDC guidance "Person who previously received passive antibody therapy or COVID-19" and client to try to find out if she was receiving a placebo, if so, she will schedule 2nd immunization at recommended time. No adverse reaction at at this time.
Patient came into our office the next day with redness and swelling from shoulder to elbow, with warmth and tenderness.
pt recv vax 20JUN97 & 21JUL97 pt devel less than 50 pimple like rash lesions w/clear fluid;
Patient reports a low grade fever started the night of the vaccination and then facial swelling on the same side as the flu shot (right).
8 days (November 22) after the vaccine my daughter began complaining that her eyelid was sore. By November 25 she developed a stye on her left upper eyelid. Then on 11/27 she developed a stye on her right lower eyelid. We sought treatment at her local eye doctor on 11/29 and began antibiotic eyedrops (polymyxin B Sulfate and Trimethoprim) . Despite using the eye drops, as of 12/6 only the lower right stye has begun to resolve. On 12/5 she  began complaining of pain on her left lower eyelid and by the morning of 12/6 she had developed a 3rd stye on her lower left eye lid.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Lot number: GJ6739) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Wilson's disease" (unspecified if ongoing), notes: Other medical history: Wilson's disease. Concomitant medication(s) included: GALZIN, start date: 01Apr2016. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. No follow-up attempts are possible. No further information is expected.
Sensation of throat swelling and difficulty swallowing, mild wheezing and coughing, pounding headache, dizziness, fatigue and lethargy, abdominal cramps, extreme pain at site of injection, hard lump at site, fever of 100 degrees, chills, muscle pain, pounding of heart in her ears, watery eyes, difficulty concentrating because so lethargic, loss of appetite, muscle aches and pains.
I got my first shot on 3.30.21, I went home, i was fine. Woke up, my arm was sore, I started getting nausea, but then I started throwing up. I thought it was normal, but then I was throwing up all day. Next day, I started throwing up white foam. Then my hand was hurting like some one spanked it. On the third day, I woke up and my vomiting was more aggressive, and my right hand was was in pain, I could not use it. If I tried to do something, it just hurt the whole hand. I called the clinic and told them that I was having a bad reaction to the shot, told them that my vomiting wont stop and my right hand is hurting. They made me an appointment. So I was back and fourth in the clinic. Those 3 weeks, it's getting worse. Clinic/NP was just giving me nausea medicine and acid reflux mediation. And wanted to give me a shot to take the pain away from my hand. But I said no more shots. The second shot, I was suppose to get it out of her clinic. I couldnt use my hand at all. Right before I got the shot, I had to get her advice. She gives me a shot, and gave me vomiting meds again and sent me for the second covid shot. I went because she's my doctor.   Went to Hospital.
She developed flushing, low blood pressure and tachycardia within 24-48 hrs. These symptoms persisted through the next week and she would have episodes where symptoms would get worse. One week later she had such an episode and had syncope associated with this. She was incontinent of urine and 911 was called. She came to about 10 mins later.  Her blood pressure was low at 80/40.
Injection give very high and anterior, above typical deltoid site. Injection itself was very painful (first time in 30+years). Progressive pain at injection site, radiating to above elbow, upper left back, shoulder, and left neck. Tingling into fingers. Within 6 hours was painful to raise arm above 90 degrees, if moved arm across my body, was not able to lift/hold parallel to the floor. Used heat, ibuprofen. 2 1/2 weeks later still have tenderness to touch at injection site and into upper back. Chronic ache does not go away unless I take ibuprofen. Due to discomfort, and some weakness reaching across body, I am overusing other muscles, discomfort and muscle tightness left upper back. Still have occasional tingling to left 3rd and 4th fingers.
Pt fell forward, was flaccid, pale & clammy; exhibited sl tremors of the upper extremities; suddenly opened eyes screamed; c/o h/a & nausea;
Arching of the back on the second day after vaccination. Arching of the back was going on for about 3 weeks. Absent seizures happening to this day. High-pitch screams out of the blue.
Pt came to get second dose of Pfizer. Was administered Janssen. Received first dose of Pfizer on 07/15/2021.
Patient was administered a Pfizer 1st dose COVID vaccine 3/26/21 & 2nd dose Moderna COVID vaccine on 4/16.
Information has been received from a retired physician concerning a female patient (young girl) (age unknown) who on an unknown date was vaccinated with a dose of GARDASIL (lot number, dose and route not reported). The physician stated that he knew that the patient had a reaction to GARDASIL. On an unknown date, the patient fainted in the office (name of the office unspecified) and later was hospitalized, released (date unspecified). At the time of reporting, the patient had not recovered and was hospitalized and in coma. Coma was considered to be immediately life-threatening and disabling per retired physician. No further information is available.
101.2 deg fever, chills, muscle ache, joint pain lasting ~18 hours.  Significant elevated tinnitus symptoms.  See also temporary  VERS #414207
t104 30min p/shot;ER d/t rt leg swelling @ site, cried-screamed all noc
Mother reports child has had low grade temp 99.3 for last 5 days, lethargy & irritability. No signs of illness.
Pt reported a multi-day headache within hours of receiving the vaccine (occurred for several hours after his second dose) and 24 hrs of vertigo.
Migraine headache that lasted four days after vaccination. Dizziness and lightheadedness that lasted one day after vaccination. Chest tightness and discomfort that started two weeks after vaccination and occurred at least once a day for seven days with episodes that lasted an average of one hour.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 31-JUL-2015, the patient was vaccinated with an improperly stored dose of VAQTA 50 U/ 1 ml (lot # K006604, expiration date 21-OCT-2015). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree/ Celsius) and the type of excursion (R/F) for each time were 240, 34 and R; 144, 31 and R. The storage criteria was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
Pediarix given when patient was due for only Dtap. No adverse reaction. Provider notified.